The Board of Directors for Merck has decided to invest 5% of 2018's retained earnings at the beginning of 2019 for a new pill press production line. The press will be depreciated over seven years with no salvage value. Total revenue is expected to increase by 3%. Merck has budgeted for a 30% income tax rate and a net income from noncontrolling interests of $15 million. All other numbers not related to this change have been budgeted to remain constant with 2018. What is the expected Return on Assets Ratio for 2019?